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Introduction
Immunity against pathogens and cancer requires cell-cell 
interactions, the type, strength, and duration of which 
determine to a large extent the ﬁ   nal outcome of the 
immune response. In this process, T  cells transiently 
interact with specialised antigen presenting cells (APCs) 
to sample the nature of the prevalent antigens in the 
body. Recognition of foreign antigen by the T  cell 
receptor (TCR) results in the strengthening of the T cell-
APC interaction, which is primarily mediated by an 
increase in the aﬃ   nity of integrins for their corresponding 
ligand in a process known as ‘inside-out signalling’ [1]. 
Th   e resulting stable interaction between a T cell and its 
cognate APC is the formation of a synapse between the 
two cells, generally referred to as the immunological 
synapse (IS) [2] owing to its similarity to the neuronal 
synapse [3]. Th  e strength and duration of cell-cell 
interactions play a critical role in the activation of T cells; 
thus, a reduced capability to interact might result in 
failure to generate a good response when needed, where-
as increased and/or sustained interaction might result in 
a breach of tolerance against self antigens, leading to the 
development of autoimmunity.
Th  e formation of a mature IS has been characterized 
recently using advances in imaging techniques [4]. Initial 
activation of the TCR leads to the rapid formation of 
microclusters that contain phosphorylated-active TCR 
associated with the proximal signalling proteins Lck, 
ZAP-70 and LAT [5,6]. Th  ese microclusters are active 
signalling structures involving the actin cytoskeleton, 
since inhibition of actin polymerization prevents their 
formation [7]. Th  e TCR microclusters coalesce to form 
the central region of the IS - known as the central 
supramolecular activation cluster (cSMAC) - which also 
contains important coreceptors, such as CD4 and CD28, 
and key signalling proteins, such as PKCθ [7-9]. Recep-
tors accommodated in the cSMAC are of small molecular 
mass, while large and heavily glycosylated proteins, such 
as LFA-1 (lymphocyte function-associated antigen 1), 
CD43, and the tyrosine phosphatase CD45, accumulate 
in a ring around the central region called the peripheral 
supramolecular activation cluster (pSMAC) [10,11]. Th  e 
mature IS with its deﬁ  ned areas is thought to control 
various cell-cell interaction-mediated processes by 
inﬂ  uencing signal transduction, leading to diﬀ  erential cell 
functions, and also signal termination and dissolution of 
cell conjugates [12,13].
Interestingly, recent studies have shown that certain 
proteins with an established function in the neuronal 
synapse are also expressed by diﬀ  erent T cell subsets. For 
example, regulatory T cells (Tregs), which are shown to 
be better poised to interact with APCs compared to naïve 
T helper (Th  ) cells, express neuropilin-1 [14]. Th  is 
molecule enhanced Treg interaction with APCs and its 
down-regulation by means of small interfering RNA 
resulted in a concomitant reduction in the ability of Tregs 
to form long-lasting synapses. Neuropilin-1 was not 
detected in naïve Th   cells and this lack of expression 
correlated with their reduced capacity to form stable 
synapses. Interestingly, ectopic expression of neuropilin-1 
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Agrin plays a crucial role in the maintenance of the 
neuromuscular junction. However, it is expressed 
in other tissues as well, including T lymphocytes, 
where cell activation induces its expression. Agrin 
from activated T cells has the capacity to induce 
aggregation of key receptors and to regulate signalling. 
Interestingly, T cells isolated from patients with 
systemic lupus erythematosus over-express Agrin and 
its co-stimulation with the T cell receptor enhances 
production of pathogenic cytokines. These early 
studies point to an important function for Agrin in 
T cell biology and make the case for a more thorough 
and systematic investigation into its role in the immune 
system.
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© 2010 BioMed Central Ltdresulted in a higher number of long-lasting interactions 
between Th   cells and APCs [14]. CRMP2 (Collapsin 
response mediator protein 2) is another neural protein 
found to be expressed in T cells and to have a role in their 
polarization and migration [15]. Down-regulation of 
CRMP2 expression dampened the chemokine-induced 
transmigratory ability of human T cells. Signiﬁ  cantly, 
CRMP2 was over-expressed in T cells from patients with 
neuroinﬂ  ammatory disease, which were found to have 
elevated transmigratory activity [15]. Relevant to this 
intense area of research is the recent association of the 
molecule Agrin with the formation of the T cell-APC IS.
The Agrin protein
Agrin was initially isolated from basal lamina extracts of 
Torpedo californica (electric ray) and shown to have the 
ability to induce diﬀ   erentiation of the postsynaptic 
membrane of muscle cells [16]. Cloning of the gene and 
follow-on studies have shown that it is produced by 
motor neurons at the neuromuscular junction (NMJ), 
where it induces aggregation of acetylcholine receptors 
on the membrane of myotubes by activating the muscle-
speciﬁ  c kinase (MuSK) [17]. Agrin is a heparan sulphate 
proteoglycan (HSPG) with a large core protein backbone 
that includes a number of distinct structural domains 
(Figure 1). Th   ere are extensive O- and N-linked glycosyla-
tions at the amino-terminal half of the protein with the 
addition of heparan sulphate glycosaminoglycan at the 
O-linked carbohydrate moieties (reviewed in [18]). Th  e 
transcript of the Agrin gene can be diﬀ  erentially spliced 
to produce diﬀ   erent isoforms of the protein, which 
determine its localization and function. Alternative 
splicing at the amino terminus produces either a type II 
transmembrane protein (TM-Agrin) or a secreted protein 
(SS-Agrin) [19,20] (Figure 1). SS-Agrin also contains a 
laminin-binding domain immediately following the 
secretion sequence, which anchors the secreted form to 
the extracellular matrix [19,20]. Th  ere are at least two 
additional splicing sites close to the carboxyl terminus of 
the protein know as A/y and B/z (A and B, and y and z 
specify the sites in the chick and mammalian proteins, 
respectively; Figure 1). Alternative splicing at these sites 
produces Agrin isoforms that contain or lack inserts at 
the A/y and B/z sites [18]. Th   e importance of splicing at 
the B/z site is well documented; inclusion of inserts (B/z+ 
forms) increases the activity of Agrin at the NMJ by many 
fold [21]. Motor neurons produce SS-B/z+ Agrin, which 
is crucial for the stabilization and functionality of the 
NMJ. Th   e Agrin form expressed in other tissues, includ-
ing T lymphocytes, is the B/z- form. Our know  ledge on 
the function of B/z- Agrin in these tissues remains 
limited at present.
Agrin is highly expressed in the brain, where its 
function has been linked to proper synaptic transmission 
of excitatory but not inhibitory synapses in the cerebral 
cortex. Mutant mice deﬁ  cient in Agrin expression have 
non-functional NMJs and die before or shortly after birth 
due to asphyxiation [22]. However, perinatal death can be 
rescued by the speciﬁ   c expression of Agrin in motor 
neurons [23]. Th  ese mice exhibit a reduced number of 
presynaptic and postsynaptic specializations in the brain, 
indicating that Agrin has a role, at least in part, in 
maintaining synaptic structure in this tissue [23]. In 
addition, Agrin is expressed at high levels in the brain 
microvasculature, where it could play a role in the 
maintenance of the blood-brain barrier [24]. Reduction 
Figure 1. Depiction of the secreted and transmembrane forms of the Agrin protein. Various structural domains of the protein are indicated by 
diff  erential colouring.
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the blood-brain barrier, possibly resulting in uncontrolled 
immune cell inﬁ  ltration.
Agrin in T cells and lupus autoimmunity
Expression of Agrin in T cells has been documented by 
Northern and Western blotting, and PCR. Initially, Khan 
and colleagues [25] reported its expression in murine 
thymocytes and splenocytes, and demonstrated that 
following T cell activation Agrin is post-translationally 
modiﬁ   ed; it migrates with increased mobility in poly-
acrylamide gels. Agrin clustered on the surface of 
activated T cells, and colocalised with the TCR and 
associated signalling proteins. Co-stimulation with anti-
CD3 and anti-Agrin antibodies augmented T cell 
prolifera  tion, particularly when low concentrations of the 
anti-CD3 antibody were used. Furthermore, puriﬁ  ed 
Agrin from activated, but not resting, T cells when added 
to the culture medium of non-activated T cells induced 
clustering of lipid rafts (lipid rafts are reviewed in [26]) 
and of the TCR [25]. Interestingly, Agrin from activated 
T cells induced clustering of acetylcholine receptors 
when added to myotube cultures, indicating that certain 
modiﬁ   cations endow the B/z- Agrin with functions 
characteristic of B/z+ Agrin [25]. Th  is is an important 
observation because most tissues express B/z- Agrin. A 
subsequent publication, using speciﬁ   c anti-sense con-
structs to down-regulate Agrin expression in lympho-
cytes, has conﬁ  rmed its importance in T cell activation 
and suggested that α-dystroglycan, a known Agrin 
receptor in other tissues, is also important for Agrin 
action in T cells [27]. Furthermore, Agrin was localized at 
the IS during antigen presentation [25,27]. Based on 
these results, it was proposed that T cell activation 
induces an as yet unknown modiﬁ  cation of Agrin that 
endows it with higher aggregating activity, and further-
more redistributes the protein to the site of the IS where 
it may facilitate antigen presentation (Figure 2).
Microarray analyses of transcripts expressed in blood 
mononuclear cells from patients with systemic lupus 
erythematosus revealed a type I interferon response 
[28-31]. Among the genes found to be upregulated was 
that encoding Agrin [28,30]. We found that both CD4+
and CD8+ T cell subsets from lupus patients expressed 
higher levels of Agrin protein compared to healthy 
controls [32]. Its expression was gradually reduced when 
the cells were cultured in vitro but was induced upon 
stimulation with anti-CD3/CD28 antibodies. A similar 
increase was seen following in vitro treatment of T cells 
with INFα. Th  erefore, factors that regulate T cell Agrin 
expression include TCR and INFα activation [32]. 
Interestingly, an investigation of the genomic position of 
Agrin in various genomes available in the databases 
reveals that in all eutherians (placental mammals), Agrin
is found immediately downstream and in the same trans-
criptional direction with the ISG-15 (Interferon stimu-
lated gene of 15 kDa) gene, which is an established type I 
INF-induced gene (Table  1). Th  e preservation of this 
genomic arrangement might indicate that type I IFNs 
control the expression of the Agrin gene; however, at 
present this is only an assumption and it remains to be 
seen whether Agrin plays a role in the INF system.
A working hypothesis on the function of Agrin in 
the immune system
Although the number of studies investigating the 
function of Agrin in the immune system is limited at 
present, based on the above results, a hypothesis can be 
put forward for future scrutiny. Agrin expression in 
T cells could be upregulated in the course of a pathogenic 
infection and, in its activated form, could interact with a 
Figure 2. Agrin localization in T cells during their in vitro 
activation. Confocal picture of a conjugate between a human CD4+ 
T cell and an anti-CD3/CD28-coated stimulatory bead. Agrin was 
visualized with the m247 anti-Agrin antibody.
Anti-Agrin immunostain
white light fluorescence
Table 1. Genomic location of the Agrin gene in genomes 
available at the National Center for Biotechnology 
Information
Species ISG15-Agrin  linkage  Chromosome
Eutheria  
 Homo  sapiens Yes  1
 Pan  troglodytes Yes  1
 Macaca  mulatta Yes  1
 Bos  Taurus Yes  16
  Canis lupus familiaris Yes 5
 Mus  musculus Yes  4
 Rattus  norvegicus Yes  5
Other  
 Caenorabditis  elegans No  II
 Gallus  gallus No  21
 Danio  rerio No  23
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contributing to the enhanced and sustained cell-cell 
adhesion required for successful T cell activation 
(Figure 3). Agrin was found to be a functional receptor 
on the surface of T cells since its crosslinking using 
speciﬁ   c antibodies resulted in activation of the ERK 
MAPK (mitogen-activated protein kinase) cascade and 
reorganisation of the actin cytoskeleton [32]. Th  erefore, 
signals generated by stimulated Agrin on the cell surface 
could result in the remodelling of the actin cytoskeleton, 
facilitating signalling by the engaged TCR (Figure 3). Th  is 
scenario agrees with recent publications highlighting the 
importance of the actin cytoskeleton in the spatio-
temporal formation of the IS and T cell activation [33]. 
Nonetheless, there is still a lot to be learned about the 
function of Agrin in T cells. Its role during activation of 
T cells in vivo remains untested; such experiments are 
awaiting the use of appropriate mouse lines and in vivo 
models. A key observation from the studies discussed 
above is that elevated Agrin expression and its post-
translational modiﬁ  cation is a characteristic of activated 
T cells. Th   is is also the case for T cells isolated from lupus 
patients. An interesting question arising from this ﬁ  nding 
is whether higher or modiﬁ   ed levels of Agrin are 
indicative of autoreactive T cells for certain types of auto-
immunity. Monitoring levels of Agrin expression in 
T cells by sampling a cohort of lupus patients with active 
and inactive disease in a longitudinal study should 
provide interesting results, and development of reagents 
such as monoclonal antibodies that are selective for 
modiﬁ  ed Agrin might prove useful as tools to monitor 
disease severity or progression.
Figure 3. Schematic illustration showing a potential function for Agrin in the context of the immunological synapse. The organization of 
key surface receptors is illustrated in the context of the mature immunological synapse structure during antigen presentation or in the absence of 
stimulation. Agrin is shown in its fully glycosylated (no activation) and modifi  ed (activation) forms. Also shown is a hypothetical receptor for Agrin 
expressed by the antigen presenting cell (APC). ICAM, intracellular adhesion molecule; LFA, lymphocyte function-associated antigen; MHC, major 
histocompatibility complex.
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Its widespread expression suggests that Agrin is 
important in other tissues. It has been reported that 
Agrin is required for eﬃ     cient transcytosis of HIV-1 
across epithelial cell monolayers by means of formation 
of the so-called ‘virological synapse’ [34]. Th  is  structure, 
formed between HIV-infected cells and healthy mucosal 
epithelial surface, supports a more eﬃ   cient  viral 
transcytosis compared to cell-free virus. Agrin expressed 
on mucosal epithelial cells bound to the envelope 
glycoprotein gp41, and this interaction substantially 
enhanced HIV-1 trancytosis [34]. Importantly, an anti-
Agrin antibody reduced virus transcytosis in vitro, 
suggest  ing that blocking Agrin on the surface of epithelial 
cells early on during infection could limit the initial viral 
load.
Agrin-null mice can be rendered viable by the restricted 
ectopic expression of Agrin speciﬁ  cally in motor neurons 
[35]. A study of these mice revealed reduced growth and 
impaired skeletal development. Examination of long 
bones showed changes in the morphology and matrix 
composition of the growth plate, most notably in the 
thickness of the hypertrophic chondrocyte zone, which 
was reduced by up to 50% [35]. Analysis of wild-type 
mice revealed high expression of Agrin in chondrocytes. 
Th  ese  ﬁ  ndings might point to an important role for Agrin 
in chondrocyte biology, the details of which, however, 
remain unexplored at present.
Agrin was found to be a major HSPG expressed in the 
glomerular basement membrane (GBM) of kidneys 
[36-38]. It wa    s initially proposed that the high anionic 
content of HSPGs in GBM is a critical factor controlling 
glomerular permeability, and the observed reduction of 
heparan sulphate levels in various renal inﬂ  ammatory 
diseases, including lupus nephritis, was associated with 
the increased GBM permeability seen in these diseases 
[39,40]. However, recent studies have directly investigated 
the contribution of Agrin to GBM functionality by using 
mutant mice deﬁ  cient for Agrin expression speciﬁ  cally in 
podocytes [41-43]. Th   ese mice, despite the strong reduc-
tion in the anionic content of the GBM, did not display 
any changes in glomerular architecture and had normal 
renal function, suggesting that Agrin is not required for 
establishment or maintenance of GBM architecture [41]. 
Th  erefore, the role of Agrin in this tissue remains 
unresolved.
Potential Agrin receptors in the immune system
Agrin is a large HSPG containing many distinct structural 
domains (Figure  1), and to date several Agrin binding 
partners have been identiﬁ   ed, including: ﬁ  broblast 
growth factor 2, which binds to Agrin heparan sulphate 
moieties [44]; α-dystroglycan and laminins [45-47], 
which are components of the extracellular matrix; 
adhesion molecules, such as neural cell adhesion mole-
cule [48]; and integrins that contain the β1 subunit [49]. 
Furthermore, the α3 subunit of the Na+/K+ ATPase 
(α3NKA) was found to serve as an Agrin receptor in 
neurons of the central nervous system [50]. Agrin 
binding to cortical neurons inhibited α3NKA activity, 
resulting in membrane depolarization and increased 
action potential frequency [50]. Also, α3NKA was found 
to mediate, at least in part, the eﬀ  ects of Agrin on cardiac 
myocyte contraction [51].
Recently, two papers have reported the long sought 
Agrin receptor expressed by the postsynaptic membrane 
at the NMJ. Th  is was found to be Lrp4 (low-density 
lipoprotein related protein 4), a member of the low-
density lipoprotein receptors [52,53]. Lrp4, upon Agrin 
binding, forms a complex with MuSK, which initiates 
intracellular signalling leading to the aggregation of 
acetylcholine receptors. Lrp4 binds to the B/z+ form of 
Agrin with an aﬃ   nity that is many fold higher compared 
to B/z- forms, conﬁ  rming the selectivity of this receptor 
for the function of Agrin at the NMJ [52,53]. It is 
conceivable that outside the NMJ, Agrin mediates its 
eﬀ  ects through additional receptors that have not been 
identiﬁ  ed yet. One report, discussed above, implicates α-
dystroglycan as an Agrin receptor in T cells [27]. 
Nevertheless, a systematic analysis and identiﬁ  cation of 
the types of Agrin receptors expressed will be an essential 
step in order to understand the biological function of 
Agrin in the immune system.
Conclusion
Although Agrin was initially identiﬁ  ed as a factor critical 
for the function of the NMJ, its expression in other 
tissues, including T cells, implies a more widespread role. 
Results from studies in T cells suggest that Agrin 
function is linked to TCR signalling and cell activation. 
Despite these initial ﬁ  ndings, there are big gaps in our 
knowledge regarding the function of Agrin in T cells and 
the immune system in general, at both the molecular 
level and at the level of the whole organism. At the 
molecular level important areas of investigation, although 
by no means the only ones, are: to understand the nature 
of Agrin modiﬁ   cation induced early on during T cell 
activation, which increases its aggregating activity; to 
explore the role of Agrin in cell-cell adhesion during 
antigen presentation; and to identify the receptor(s) that 
mediate the eﬀ   ects of Agrin in immune cells. At the 
organism level, vital information will be generated by: 
studying how T cells and the immune system in general 
develop in the absence of Agrin expression; assessing 
changes in immune responses of viable Agrin-/- mice 
compared to wild type; and studying whether higher 
expression of Agrin in T cells in engineered mice 
predisposes to T cell hyperactivity and autoimmunity. 
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Agrin and we anticipate that these issues will be 
addressed in the near future by immunologists with 
diﬀ  erent areas of expertise. Th   ese studies may well prove 
that Agrin has a critical role in the immune system as it 
has in the NMJ.
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